SUMMARY A mathematical model has been developed to assess the contribution of 32p in the blood in the choroidal vessels to the count obtained from the eye during the 32p uptake test. Applying the model at 48 hours after the administration of 32p it was found that, at this time, between 4% and 7% of the control count on the eye was due to 32P activity in the choroidal blood.
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In a previous paper' the authors described their experience of the 32P uptake test in the diagnosis of intraocular malignancies and discussed some of the factors affecting the uptake. The 32p test is based on the differential accumulation of radioactive phosphorus between neoplastic and non-neoplastic tissue following an intravenous injection of the isotope. Counts are recorded from a site on the surface of the eye, overlying the lesion, and from a control site on 
Materials and methods
A brief outline of the method may help in the understanding of the use of the model. Blood is withdrawn from an antecubital vein from a patient who has received 32P, and the sample is counted by placing the same probe as used on the eye in contact with the blood in a suitable chamber. It is assumed that the concentration of 32P in the blood is uniform throughout the body, so that the concentration of isotope in the blood sample is the same as in the blood in the vessels of the choroid. It is further assumed that the attenuation of f8 particles is the same in ocular tissue and in blood. The count recorded from the blood sample may be thought of as being derived from a series of bands at different levels within the sample. The contribution of each band to the total count recorded from the blood sample is obtained from the model. One of the bands in the blood sample is at the same distance from the probe as the choroid in the eye. The model determines the fraction of total blood sample count that is derived from the band which corresponds to the choroid. On the assumption that blood is the major component (Fig. 2) . The activity which reaches the detecting element depends on 2 factors. The first is the attenuation of radiation as it passes through matter, dependent on the distance and the attenuation coefficient. In the model the attenuation coefficient of water was used. Secondly, since radiation is emitted in all directions, only that radiation which falls on the detector element is measured. thus the activity which reaches the detector element depends on the degree of attenuation and the fractional angle of pick-up. The equation which describes this is given in Fig. 2 . The activity at the detector from the point (a, b) is the sum of the detected activities at all the detector points, and from this an activity number is ascribed to the point (a, b).
In the model, activity numbers were obtained for each of the 35 x 110 source points, and the total of all the activity numbers was obtained. The equations were solved by means of an IBM 360/165 computer. The ratio of the activity number from any source point to the total of all the activity numbers in the matrix is equal to the fractional contribution from that source point to the counts at the detector from a uniform source distribution.
The model may be applied to the contribution of the 32P in the blood of the choroid to the count obtained on the surface of the eye as follows. If the sclera is taken as 400 ,um thick and the choroid as 200 group.bmj.com on August 28, 2017 -Published by http://bjo.bmj.com/ Downloaded from ,um, the choroidal points are represented by the third row of the matrix. The ratio of the counts derived from the clhoroid to counts obtained from a uniform source distribution is the ratio of the activity numbers of the third row to the total of all the activity numbers. A uniform source distribution may be achieved by using an arrangement similar to that of Fig. I to count blood from a patient who has received 32p, with the eye probe in contact with the blood sample. In 4 patients undergoing 32P tests, 48 hours after an intravenous dose of 500 ,uCi of 32p, test and control eye counts were measured, and at the same time venous blood was withdrawn from an antecubital vein. These blood samples were placed in a container, and radioactivity was determined by placing the detector in contact with this blood.
Results
The measured radioactivity from blood samples in 4 patients varied from 557 to 837 counts/100 s.
In the model the counts derived from the third row of the matrix, which corresponded to the choroidal layer, comprised 4% of those from a uniform distribution. The third and fourth rows of the matrix each contributed 4% to the total count, so that the exact location of the choroid did not appreciably affect the final conclusions. Thus, the predicted contribution to the control site count derived from blood in the choroid ranged between 24 and 36 counts/100 s ( Table 1) .
The counts recorded at the control site in the 4 patients ranged between 337 and 707 counts/100 s. The mathematical analogue described in this paper is useful because of the paucity of experimental information. It is particularly difficult to obtain a direct measurement of the contribution of blood-borne 32p to the counts recorded on the sclera during an uptake measurement. The model may also be applied to distributions of 32P other than those detailed. The interpoint spacing may be reduced if greater resolution is required provided the number of points is increased to maintain the overall dimensions of the matrix. The model is applicable to other postinjection times provided blood is withdrawn and counted by the eye probe. The application of the model to nonvascular 32P may be made only if the concentration and distribution of isotope in the nonvascular component are known.
